selegiline has been researched along with tryptamine in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (57.14) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gozalbes, R; Pineda-Lucena, A | 1 |
| Nicotra, A; Scopelliti, R; Senatori, O | 1 |
| Greenshaw, AJ; Juorio, AV; Nguyen, TV | 1 |
| Farrell, MA; Hardiman, OM; McDonnell, L; Phillips, JP; Sullivan, JP; Tipton, KF | 1 |
| Graham, D; Langer, SZ | 1 |
| Harik, SI; Kalaria, RN | 1 |
| Grimm, LJ; Kellar, KJ; Kettler, KG; Perry, DC | 1 |
| Duvoisin, RC; Heikkila, RE; Hess, A | 1 |
| Cabbat, FS; Duvoisin, RC; Heikkila, RE; Manzino, L | 1 |
| Duvoisin, RC; Finberg, JP; Heikkila, RE; Youdim, MB | 1 |
| Knoll, B; Knoll, J; Miklya, I; Moto, T; Ohde, H; Sakae, M; Yoneda, F | 1 |
| Bellik, L; Marco, JI; Romera, M; Sanz, E; Unzeta, M | 1 |
| Gaszner, P; Miklya, I | 2 |
2 review(s) available for selegiline and tryptamine
| Article | Year |
|---|---|
The use of the synthetic enhancer substances (-)-deprenyl and (-)-BPAP in major depression.
Topics: Benzofurans; Catecholamines; Depressive Disorder, Major; Humans; Mesencephalon; Neuroprotective Agents; Selegiline; Serotonin Agents; Tryptamines | 2004 |
Major depression and the synthetic enhancer substances, (-)-deprenyl and R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane.
Topics: Animals; Benzofurans; Depressive Disorder, Major; Humans; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Selegiline; Tryptamines | 2006 |
12 other study(ies) available for selegiline and tryptamine
| Article | Year |
|---|---|
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Monoamine oxidase activity in embryos of pike (Esox lucius).
Topics: Animals; Blastocyst; Cleavage Stage, Ovum; Clorgyline; Gastrula; Mitochondria; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Ovum; Phenethylamines; Salmonidae; Selegiline; Serotonin; Tryptamines | 1990 |
Lesion-induced reductions in trace amine accumulation: dependence on MAO inhibitor pretreatment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Amines; Corpus Striatum; Dopamine; Homovanillic Acid; Hydroxydopamines; Male; Monoamine Oxidase Inhibitors; Oxidopamine; Pargyline; Rats; Rats, Inbred Strains; Selegiline; Substantia Nigra; Tryptamines | 1989 |
The oxidation of tryptamine by the two forms of monoamine oxidase in human tissues.
Topics: Brain; Clorgyline; Humans; Kidney; Kinetics; Liver; Monoamine Oxidase; Oxidation-Reduction; Selegiline; Tryptamines | 1986 |
[3H]tryptamine binding sites of rat cerebral cortex: pharmacological profile and plasticity.
Topics: Animals; Binding Sites; Carbolines; Cerebral Cortex; Clorgyline; Kinetics; Male; Phenethylamines; Rats; Rats, Inbred Strains; Selegiline; Structure-Activity Relationship; Tryptamines | 1987 |
Differential postnatal development of monoamine oxidases A and B in the blood-brain barrier of the rat.
Topics: Aging; Animals; Benzylamines; Blood-Brain Barrier; Brain; Cerebral Cortex; Clorgyline; Microcirculation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; Rats; Rats, Inbred Strains; Selegiline; Substrate Specificity; Tryptamines | 1987 |
[3H]tryptamine binding sites are not identical to monoamine oxidase in rat brain.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Binding, Competitive; Brain; Clorgyline; Male; Mitochondria; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; Pyridines; Rats; Rats, Inbred Strains; Selegiline; Synaptosomes; Tissue Distribution; Tryptamines | 1988 |
Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in the mouse: relationships between monoamine oxidase, MPTP metabolism and neurotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Benzylamines; Clorgyline; Corpus Striatum; Dopamine; Homovanillic Acid; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Pyridines; Selegiline; Substantia Nigra; Synaptosomes; Tryptamines | 1985 |
Studies on the oxidation of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase B.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Allylamine; Animals; Benzylamines; Brain; Clorgyline; Indans; Kinetics; Mice; Mice, Inbred C57BL; Mitochondria; Monoamine Oxidase; Oxidation-Reduction; Pyridines; Selegiline; Tryptamines | 1985 |
Prevention of MPTP-induced neurotoxicity by AGN-1133 and AGN-1135, selective inhibitors of monoamine oxidase-B.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzylamines; Brain; Dopamine; Indans; Indenes; Male; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxidation-Reduction; Pargyline; Pyridines; Selegiline; Tryptamines | 1985 |
Structure-activity studies leading to (-)1-(benzofuran-2-yl)-2-propylaminopentane, ((-)BPAP), a highly potent, selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain.
Topics: Amphetamines; Amyloid; Animals; Avoidance Learning; Benzofurans; Brain; Brain Stem; Catecholamines; Cells, Cultured; Electric Stimulation; Hippocampus; Monoamine Oxidase; Neurons; Phenethylamines; Rats; Selegiline; Serotonin; Structure-Activity Relationship; Tryptamines; Tyramine | 2001 |
Indolalkylamines derivatives as antioxidant and neuroprotective agents in an experimental model of Parkinson's disease.
Topics: Animals; Antioxidants; Antiparkinson Agents; Brain; Brain Chemistry; Cell Line, Tumor; Dopamine; Dose-Response Relationship, Drug; Humans; Indoles; Melanins; Monoamine Oxidase Inhibitors; Neuroblastoma; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Selegiline; Tryptamines | 2004 |